MDXG - MiMedx Group Inc logo

MDXG

MiMedx Group Inc

MiMedx Group develops and distributes placental tissue allografts for wound care and surgical applications, utilizing its PURION process to maintain biological properties. It sells products like EPIFIX and AMNIOFIX through a direct sales force and distributors.

โš•๏ธ Healthcare NASDAQ Listed 2007 $ USD
$1,000 invested 10 years ago โ†’$569today

Score Overview

1 Year
Score
Net Growth-87.16%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-15.16%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score5.9
Net Growth150.70%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth46.75%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-47.91%
Net Trend40%
Net Income Consistency
Rev Growth44.96%
Rev Trend60%
Revenue Consistency
All Time
Scoreโ€”
Net Growth162x
Net Trend58%
Net Income Consistency
Rev Growthโ€”
Rev Trend75%
Revenue Consistency

See the full market ranking โ†’

MiMedx Group Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 248M to $ 418M and net income went from -$ 49M to $ 48M. Revenue increased in 4 of those 5 years; net income in 2.

Between 2015 and 2025, revenue grew from $ 187M to $ 418M and net income grew from $ 29M to $ 48M. Revenue increased in 6 of those 10 years; net income in 4.

MiMedx Group Inc currently holds a 5-year HDB Score of 5.9 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 4.28โ€”
1 Year2025-08-12
$ 7.23-40.80%
5 Years2021-08-12
$ 12.55-65.90%
10 Years2016-08-12
$ 7.52-43.09%
All Time2007-08-22
$ 0.1042x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 355M$ 6M$ 135M
2025$ 418M$ 48M$ 166M
2024$ 348M$ 42M$ 104M
2023$ 321M$ 67M$ 82M
2022$ 267M-$ 30M$ 65M
2021$ 242M-$ 12M$ 87M
2020$ 248M-$ 49M$ 95M
2019$ 359M-$ 29M$ 45M
2018$ 359M-$ 29M$ 45M
2017$ 321M$ 64M$ 27M
2016$ 245M$ 11M$ 34M
2015$ 187M$ 29M$ 31M
2014$ 118M$ 6M$ 52M
2013$ 59M-$ 4M$ 44M
2012$ 27M-$ 7M$ 6M
2011$ 7M-$ 10M$ 4M
2010$ 788.87K-$ 11M$ 1M
2009-$ 11M$ 2M
2008-$ 17M$ 6M
IPO2007-$ 38.86K$ 184.00

Explore beyond MDXG

You're looking at MiMedx Group Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies